# How a Promising Pancreatic Cancer Drug Loses Its Punch

> **Open Intelligence Dossier** · First detected: 2026-10-04 16:00 UTC · Category: Health

## Executive Summary
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;How a Promising Pancreatic Cancer Drug Loses Its Punch&quot; is generating significant coverage in the Health category, with 6 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Targeted Oncology, Oncodaily, Centre Daily Times and Yahoo Finance. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Targeted Oncology | Phase 3 Trial of Daraxonrasib Plus Zoldonrasib Begins in RAS G12D PDAC | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxOUE9BamNQZGpWZDFiVU9tRkpUUWlCdTFjOGs3MkdYZ2RUdERucXFINV8zWDNERGgzZ3V3bFFCNXZtZW85X3o4RXZYdnE3c1p4djhRWlBQX20wMjlXUHIwem1zVlJlZ0xpZ3BjZmx5bzFBNGxHUkJBMWJXYUNlQ0tKdzlCWkxNcVpfdTB5QWxR?oc=5) |
| Oncodaily | Phase 3 RASolute 309 Trial Begins: RASONQUE Plus Zoldonrasib in First-Line RAS G12D PDAC | [Source Link](https://news.google.com/rss/articles/CBMibEFVX3lxTFBEQ0tneEZmNHlUNkJPVXRmZUhLaHg4elRCd2pHNWlqeGhNVVRRSGUwdGJmNHc4bi01emVKMkNRZDZvNUlYSzVxNGE3WU92c1pvMEZEWW9vekQ3dnkzSGpnOXNfTlpZRzlrZUNtWA?oc=5) |
| Centre Daily Times | Two new cancer medications are available at OhioHealth | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxOb1VHVFpCMG0tbm13b2hQSXVybUQxa1RDTDg1NGZHemZCMUNJQ2V1d25kbnVNdFJtTHNMNDh6djVCbGRzX2VpaV9wMi0yTFJSVFFCYjZ6ei14aHhBLTdiZlZBNExJT0xLc09mUVdwWGZRRGVYazVCMjBlOUwwYjI4OXlR?oc=5) |
| Yahoo Finance | Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaDJFamZJd1JqQVFaTTF6UnVSaWlPY1EtemVleUNVQ3BpVWl2d1hVczNDWUJMTDl0bFQxTkZQenpNU09lRVlCcUFZVkJWYW9CV1lxTzVsN0RING1adWFldW56S1dFWERKdHY3a3lrb092MUxWeUhWa3JpeWhXVjFyeFp5aHdwZVZQYWlqclN6OXF3RVJ4WE1EYnpUZGN0eVhxWTBQU21LZ082UQ?oc=5) |
| Mansfield News Journal | Two new cancer medications are available at OhioHealth | [Source Link](https://news.google.com/rss/articles/CBMi0AFBVV95cUxQdDBhMkwxM2gtR3ZySWJOOTJBb2xqb21xV2RiSy1KRHI3RVZUeldWRXJobU5BTTYzNElQaGc3eUpOT09IZEtQRkdxY0RQTlBid0htLW5nNUlQTGR5TTZmQV9NU2tmX1d6bFBRQ2loaVI1NU5QRGpoRTdXYWMtc1Bfbk9lcS1fdVZKeWNRTmY2d2xRU09yTFBSb3BpUXh5NTZnbzBzS19PWHVlaG5aWFdPaW5ia2N6ZzFEb0FmOUJzSEFlUG1wY0lfRFhYak9tUG1o?oc=5) |
| Newser | How a Promising Pancreatic Cancer Drug Loses Its Punch | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxQemF0R3Y2dGo1NE1qLXMzdFUyVkw0cXRXZG9GWFp1b19zVk41TUdsN0ZQVm96NEFqMlY2QVZFNGtuRU1HNTJydFhzckxFdDN1T21yZUllNi02dWMtM1BtN0hLWi0tb1NyczlnNFI5QUZQcVBlV0lSOGZ0LS1oS3JhYU5lZWZLVEgyR0cxMFRHYTZiUUVEUC03bjdKaw?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-04/how-a-promising-pancreatic-cancer-drug-loses-its-punch*
